SETD1B (Q9UPS6) variants and mutations
SETD1B (also known as Q9UPS6) is a human protein-coding gene encoding a histone-lysine N-methyltransferase protein. A histone methyltransferase that places H3K4 methyl marks and helps regulate gene expression. Pathogenic variants can cause a neurodevelopmental disorder with intellectual disability and seizures. This analysis covers 2,368 SETD1B variants and mutations. Of these, 98% have computational variant effect predictions. Disease context includes intellectual developmental disorder with seizures and language delay, hereditary disease, and neurodevelopmental disorder. Example SETD1B variants include E2D, E2Q, and N3S.
Variant analysis overview
- Gene: SETD1B
- Protein: Q9UPS6
- UniProt accession: Q9UPS6
- Organism: Homo sapiens
- Variants analyzed: 2368
- Variant scope: all variants
- Completed: 2026-10-09
Variant and mutation evidence
- Variant composition: 2,217 unspecified-consequence records; 93 missense variants; 102 synonymous variants; 6 in-frame deletions; 7 frameshift variants; 2 in-frame insertions; 2 splice-region variants; 1 stop-gained variants; 3 substitution
- Prediction scores: 2,314 variants have prediction scores (98% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: intellectual developmental disorder with seizures and language delay, hereditary disease, neurodevelopmental disorder, complex neurodevelopmental disorder, autosomal dominant non-syndromic intellectual disability, Global developmental delay, Abnormality of the skeletal system, epilepsy, Neurodevelopmental delay, lung adenocarcinoma, head and neck squamous cell carcinoma, gastric adenocarcinoma.
Protein structure and variant hotspots
- Protein features: 3 domains; 1 binding sites; 8 post-translational modification sites.
- Structural context: 242 variants have structural context.
- PTM context: 7 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Diseases linked to SETD1B
Notable SETD1B variants
Examples include E2D, E2Q, N3S, N3T, N3K, N3N, S4G, S4I. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- E2D (p.Glu2Asp), Ensembl rs1875634266, cosmic curated COSV11397, REVEL 0.29, ESM-1b 0.00
- E2Q (p.Glu2Gln), gnomAD 12-121804741-G-C, REVEL 0.33, ESM-1b 0.00
- N3S (p.Asn3Ser), cosmic curated COSV10803, ESM-1b 0.00, AlphaMissense 0.21
- N3T (p.Asn3Thr), gnomAD 12-121804745-A-C, REVEL 0.36, ESM-1b 0.00
- N3K (p.Asn3Lys), gnomAD 12-121804746-C-G, REVEL 0.32, ESM-1b 0.00
- N3N (p.Asn3Asn), rs1043558709, gnomAD 12-121804746-C-T, CADD 14.40
- S4G (p.Ser4Gly), TOPMed rs1875634639, ESM-1b 0.00, AlphaMissense 0.16
- S4I (p.Ser4Ile), cosmic curated COSV10803, ESM-1b 0.13, AlphaMissense 0.33
- S4N (p.Ser4Asn), gnomAD rs1460732622, REVEL 0.37, ESM-1b 0.00
- S4S (p.Ser4Ser), rs1204497757, gnomAD 12-121804749-T-C, CADD 14.40
- H5P (p.His5Pro), gnomAD rs990629163, REVEL 0.41, ESM-1b 0.00
- H5H (p.His5His), rs903593177, gnomAD 12-121804752-C-T, CADD 12.60
- P6A (p.Pro6Ala), TOPMed rs1245178468, gnomAD rs1245178468, REVEL 0.36, ESM-1b 0.00
- P6H (p.Pro6His), 1000Genomes rs553235589, ExAC rs553235589, TOPMed rs553235589, gnomAD rs553235589, REVEL 0.32, ESM-1b 0.00, Likely benign, SETD1B-related disorder
- P6L (p.Pro6Leu), 1000Genomes rs553235589, ExAC rs553235589, TOPMed rs553235589, gnomAD rs553235589, REVEL 0.39, ESM-1b 0.00, Uncertain significance
- P6R (p.Pro6Arg), rs553235589, ClinGen CA386986786, ClinVar RCV003493152, ClinVar RCV004961341, REVEL 0.40, ESM-1b 0.00, Uncertain significance, Inborn genetic diseases; Intellectual developmental disorder with seizures and l
- p.Pro6 His8del, rs2137541518, gnomAD 12-121804749-TCAC, CADD 20.60
- P6T (p.Pro6Thr), gnomAD 12-121804753-C-A, REVEL 0.34, ESM-1b 0.00
- P6P (p.Pro6Pro), rs748729469, gnomAD 12-121804755-C-T, CADD 14.50
- P7A (p.Pro7Ala), gnomAD rs1373777370, REVEL 0.26, ESM-1b 0.00
- P7H (p.Pro7His), cosmic curated COSV57348, TOPMed rs1052521826, gnomAD rs1052521826, REVEL 0.34, ESM-1b 0.00, Uncertain significance
- P7L (p.Pro7Leu), rs1052521826, ClinGen CA386986791, ClinVar RCV002272829, TOPMed rs1052521826, REVEL 0.28, ESM-1b 0.00, Uncertain significance, Intellectual developmental disorder with seizures and language delay
- P7R (p.Pro7Arg), TOPMed rs1052521826, gnomAD rs1052521826, REVEL 0.34, ESM-1b 0.00, Uncertain significance
- P7S (p.Pro7Ser), gnomAD rs1373777370, REVEL 0.25, ESM-1b 0.00
- p.Pro7dup, gnomAD 12-121804751-A-AC, CADD 21.00
- P7del (p.Pro7del), rs777278685, gnomAD 12-121804751-ACCC, CADD 18.10
- P7T (p.Pro7Thr), gnomAD 12-121804756-C-A, REVEL 0.26, ESM-1b 0.00
- P7P (p.Pro7Pro), rs1242193997, gnomAD 12-121804758-C-G, CADD 14.20
- H8D (p.His8Asp), ExAC rs770426488, TOPMed rs770426488, gnomAD rs770426488, REVEL 0.32, ESM-1b 0.88, Uncertain significance
- H8N (p.His8Asn), ExAC rs770426488, TOPMed rs770426488, gnomAD rs770426488, REVEL 0.34, ESM-1b 0.47, Uncertain significance, not specified
- H8P (p.His8Pro), rs773794483, ClinGen CA6838733, cosmic curated COSV57349, ClinVar RCV003390318, REVEL 0.35, ESM-1b 0.00, Benign/Likely benign, not specified; not provided
- H8Q (p.His8Gln), rs901546350, TOPMed rs901546350, gnomAD rs901546350, ClinGen CA386986796, REVEL 0.33, ESM-1b 0.00, Uncertain significance, SETD1B-related disorder
- H8Y (p.His8Tyr), ExAC rs770426488, TOPMed rs770426488, gnomAD rs770426488, REVEL 0.30, ESM-1b 0.00, Uncertain significance
- H8T (p.His8Thr), rs777278685, gnomAD 12-121804751-AC-A, CADD 24.70
- H8R (p.His8Arg), gnomAD 12-121804760-A-G, REVEL 0.29, ESM-1b 0.09
- H8H (p.His8His), rs901546350, gnomAD 12-121804761-C-T, CADD 12.90
- H9P (p.His9Pro), cosmic curated COSV57347, ExAC rs763428639, gnomAD rs763428639, REVEL 0.36, ESM-1b 0.00
- p.His9 His11del, gnomAD 12-121804757-CCCA, CADD 19.60
- H9Y (p.His9Tyr), gnomAD 12-121804762-C-T, REVEL 0.27, ESM-1b 0.19
- H9Q (p.His9Gln), gnomAD 12-121804764-C-A, REVEL 0.37, ESM-1b 0.00
- H10P (p.His10Pro), cosmic curated COSV10876, gnomAD rs916407832, REVEL 0.37, ESM-1b 0.00
- H10Q (p.His10Gln), cosmic curated COSV11397, 1000Genomes rs763848081, TOPMed rs763848081, gnomAD rs763848081, REVEL 0.33, ESM-1b 0.00, Likely benign, not provided
- H11P (p.His11Pro), cosmic curated COSV10876, ExAC rs771290613, gnomAD rs771290613, REVEL 0.35, ESM-1b 0.00
- H11Q (p.His11Gln), rs571737223, 1000Genomes rs571737223, ExAC rs571737223, TOPMed rs571737223, REVEL 0.29, ESM-1b 0.00, Benign, Inborn genetic diseases
- H11R (p.His11Arg), ExAC rs771290613, gnomAD rs771290613, REVEL 0.29, ESM-1b 0.31
- H11Y (p.His11Tyr), gnomAD rs1400120120, REVEL 0.28, ESM-1b 0.01
- p.His11dup, rs756897560, gnomAD 12-121804757-C-CC, CADD 18.90
- H11del (p.His11del), rs756897560, gnomAD 12-121804757-CCCA, CADD 19.00
- Q12H (p.Gln12His), Ensembl rs1875640725, REVEL 0.33, ESM-1b 0.00
- Q12R (p.Gln12Arg), gnomAD rs1316945004, REVEL 0.31, ESM-1b 0.00
- Q12P (p.Gln12Pro), gnomAD 12-121804771-CAG-, CADD 28.30
- Q13del (p.Gln13del), rs879887994, gnomAD 12-121804770-CCAG, CADD 19.80
- Q13K (p.Gln13Lys), gnomAD 12-121804774-C-A, REVEL 0.17, ESM-1b 0.47
- Q13P (p.Gln13Pro), gnomAD 12-121804774-CAG-, CADD 27.60
- Q13Q (p.Gln13Gln), gnomAD 12-121804776-G-A, CADD 12.00
- Q13H (p.Gln13His), gnomAD 12-121804776-G-C, REVEL 0.29, ESM-1b 0.00
- P14S (p.Pro14Ser), gnomAD rs1326516333, REVEL 0.25, ESM-1b 0.18
- P14L (p.Pro14Leu), gnomAD 12-121804778-C-T, REVEL 0.29, ESM-1b 0.00
- P14H (p.Pro14His), gnomAD 12-121804778-C-A, REVEL 0.26, ESM-1b 0.00
- P15L (p.Pro15Leu), ExAC rs759783691, TOPMed rs759783691, gnomAD rs759783691, REVEL 0.26, ESM-1b 0.00, Uncertain significance, SETD1B-related disorder
- P15S (p.Pro15Ser), gnomAD 12-121804780-C-T, REVEL 0.24, ESM-1b 0.00
- P15A (p.Pro15Ala), gnomAD 12-121804780-C-G, REVEL 0.24, ESM-1b 0.00
- P15R (p.Pro15Arg), gnomAD 12-121804781-C-G, REVEL 0.22, ESM-1b 0.41
- P15P (p.Pro15Pro), gnomAD 12-121804782-G-A, CADD 14.40
- P16S (p.Pro16Ser), gnomAD 12-121804783-C-T, REVEL 0.22, ESM-1b 0.00
- P16R (p.Pro16Arg), gnomAD 12-121804784-C-G, REVEL 0.30, ESM-1b 0.11
- P16Q (p.Pro16Gln), gnomAD 12-121804784-C-A, REVEL 0.28, ESM-1b 0.00
- P16P (p.Pro16Pro), rs1432765773, gnomAD 12-121804785-G-A, CADD 14.40
- Q17P (p.Gln17Pro), gnomAD 12-121804787-A-C, REVEL 0.48, ESM-1b 0.00
- Q17H (p.Gln17His), gnomAD 12-121804788-G-C, REVEL 0.40, ESM-1b 0.00
- Q17Q (p.Gln17Gln), gnomAD 12-121804788-G-A, CADD 12.50
- P18S (p.Pro18Ser), gnomAD 12-121804789-C-T, REVEL 0.21, ESM-1b 0.00
- P18L (p.Pro18Leu), gnomAD 12-121804790-C-T, REVEL 0.35, ESM-1b 0.15
- P18P (p.Pro18Pro), rs1023080113, gnomAD 12-121804791-C-T, CADD 14.50
- G19S (p.Gly19Ser), Ensembl rs1875641455, ESM-1b 0.00, AlphaMissense 0.23
- P20L (p.Pro20Leu), TOPMed rs1281324968, gnomAD rs1281324968, REVEL 0.30, ESM-1b 0.00
- P20R (p.Pro20Arg), TOPMed rs1281324968, gnomAD rs1281324968, ESM-1b 0.00, AlphaMissense 0.54
- P20P (p.Pro20Pro), rs1592972638, gnomAD 12-121804797-T-C, CADD 14.70
- S21* (p.Ser21Ter), rs12814488, ClinGen CA386986877, ClinVar RCV003137337, AlphaMissense 0.57, MetaLR 0.82, Pathogenic
- S21L (p.Ser21Leu), Ensembl rs12814488, ESM-1b 0.00, AlphaMissense 0.52, Pathogenic
- G22C (p.Gly22Cys), gnomAD 12-121804801-G-T, REVEL 0.48, ESM-1b 0.31
- G22D (p.Gly22Asp), gnomAD 12-121804802-G-A, REVEL 0.39, ESM-1b 0.00
- E23D (p.Glu23Asp), ExAC rs767553186, TOPMed rs767553186, gnomAD rs767553186, REVEL 0.37, ESM-1b 0.00
- R24K (p.Arg24Lys), TOPMed rs1875642469, gnomAD rs1875642469, REVEL 0.18, ESM-1b 0.00
- R24R (p.Arg24Arg), rs1875642673, gnomAD 12-121804809-G-A, CADD 14.10
- R25K (p.Arg25Lys), cosmic curated COSV57352, TOPMed rs954297627, gnomAD rs954297627, REVEL 0.20, ESM-1b 0.00
- R25R (p.Arg25Arg), rs1875643022, gnomAD 12-121804812-G-A, CADD 13.60
- N26T (p.Asn26Thr), gnomAD 12-121804814-A-C, REVEL 0.27, ESM-1b 0.00
- H27Q (p.His27Gln), TOPMed rs1875643225, ESM-1b 0.00, AlphaMissense 0.79
- H28H (p.His28His), rs1264848570, gnomAD 12-121804821-T-C, CADD 11.10
- W29* (p.Trp29Ter), TOPMed rs1438201003, gnomAD rs1438201003, CADD 37.00
- W29C (p.Trp29Cys), TOPMed rs1438201003, gnomAD rs1438201003, REVEL 0.76, ESM-1b 0.11
- W29G (p.Trp29Gly), gnomAD rs1875643602, ESM-1b 0.00, AlphaMissense 0.97
- W29R (p.Trp29Arg), gnomAD rs1875643602, REVEL 0.59, ESM-1b 0.00
- R30K (p.Arg30Lys), rs752819288, ClinGen CA6838739, ClinVar RCV002310612, ExAC rs752819288, REVEL 0.33, ESM-1b 0.00, Uncertain significance, Intellectual developmental disorder with seizures and language delay
- R30S (p.Arg30Ser), gnomAD 12-121804827-A-C, REVEL 0.60, ESM-1b 0.00
- S31N (p.Ser31Asn), gnomAD 12-121804829-G-A, REVEL 0.34, ESM-1b 0.00
- Y32* (p.Tyr32Ter), gnomAD rs1875644203, CADD 36.00
- Y32D (p.Tyr32Asp), cosmic curated COSV10725, ESM-1b 1.00, AlphaMissense 1.00
- K33K (p.Lys33Lys), gnomAD 12-121804836-G-A, CADD 13.60
- L34L (p.Leu34Leu), rs1277287156, gnomAD 12-121804837-T-C, CADD 14.00
- M35I (p.Met35Ile), rs971066640, ClinGen CA244632292, ClinVar RCV002798552, TOPMed rs971066640, REVEL 0.24, ESM-1b 0.00, Likely benign, Inborn genetic diseases
- M35R (p.Met35Arg), cosmic curated COSV10725, ESM-1b 0.00, AlphaMissense 1.00
- I36V (p.Ile36Val), TOPMed rs1459447704, ESM-1b 0.00, AlphaMissense 0.42
- P38S (p.Pro38Ser), gnomAD 12-121804849-C-T, REVEL 0.82, ESM-1b 1.00
- P38P (p.Pro38Pro), rs760682202, gnomAD 12-121804851-G-A, CADD 14.10
- A39G (p.Ala39Gly), gnomAD 12-121804853-C-G, REVEL 0.32, ESM-1b 0.00
- A39V (p.Ala39Val), gnomAD 12-121804853-C-T, REVEL 0.44, ESM-1b 0.00
- L40L (p.Leu40Leu), rs1875645162, gnomAD 12-121804855-C-T, CADD 13.00
- K42R (p.Lys42Arg), gnomAD 12-121804862-A-G, REVEL 0.34, ESM-1b 0.00
- K42K (p.Lys42Lys), rs1875645359, gnomAD 12-121804863-G-A, CADD 13.30
- K42N (p.Lys42Asn), gnomAD 12-121804863-G-T, REVEL 0.50, ESM-1b 0.00
- G43G (p.Gly43Gly), rs1272757648, gnomAD 12-121804866-G-T, CADD 13.20
- H44I (p.His44Ile), gnomAD 12-121804866-GC-G, CADD 27.20
- H44Y (p.His44Tyr), gnomAD 12-121804867-C-T, REVEL 0.30, ESM-1b 0.00
- H44Q (p.His44Gln), gnomAD 12-121804869-T-G, REVEL 0.27, ESM-1b 0.00
- H45Q (p.His45Gln), gnomAD rs1448838425, REVEL 0.32, ESM-1b 0.00
- L47M (p.Leu47Met), cosmic curated COSV57354, REVEL 0.55, ESM-1b 1.00
- L47V (p.Leu47Val), gnomAD 12-121804876-C-G, REVEL 0.27, ESM-1b 0.76
- L47L (p.Leu47Leu), gnomAD 12-121804876-C-T, CADD 13.10
- Y48C (p.Tyr48Cys), cosmic curated COSV10875, ESM-1b 1.00, AlphaMissense 0.97
- Y48Y (p.Tyr48Tyr), rs764034236, gnomAD 12-121804881-C-T, CADD 11.70
- R49R (p.Arg49Arg), gnomAD 12-121804884-C-A, CADD 14.40
- Y50F (p.Tyr50Phe), TOPMed rs1015335173, gnomAD rs1015335173, REVEL 0.72, ESM-1b 1.00, Uncertain significance, Inborn genetic diseases
- Y50Y (p.Tyr50Tyr), rs1179011662, gnomAD 12-121804887-C-T, CADD 12.70
- D51N (p.Asp51Asn), cosmic curated COSV57348, ESM-1b 0.00, AlphaMissense 0.97
- D51Y (p.Asp51Tyr), cosmic curated COSV57347, ESM-1b 1.00, AlphaMissense 1.00
- G52G (p.Gly52Gly), gnomAD 12-121804893-G-A, CADD 14.20
- Q53Q (p.Gln53Gln), gnomAD 12-121804896-G-A, CADD 12.70
- H54Y (p.His54Tyr), gnomAD rs1362433895, REVEL 0.36, ESM-1b 0.00
- H54N (p.His54Asn), gnomAD 12-121804897-C-A, REVEL 0.28, ESM-1b 0.00
- H54L (p.His54Leu), gnomAD 12-121804898-A-T, REVEL 0.47, ESM-1b 0.00
- S56N (p.Ser56Asn), TOPMed rs1247959969, gnomAD rs1247959969, REVEL 0.23, ESM-1b 0.00, Uncertain significance, not provided
- S56G (p.Ser56Gly), gnomAD 12-121804903-A-G, REVEL 0.32, ESM-1b 0.00
- S56R (p.Ser56Arg), gnomAD 12-121804905-C-A, REVEL 0.69, ESM-1b 0.00
- L57L (p.Leu57Leu), gnomAD 12-121804908-G-C, CADD 13.10
- A58V (p.Ala58Val), TOPMed rs973837174, REVEL 0.27, ESM-1b 0.00
- A58A (p.Ala58Ala), rs1451088806, gnomAD 12-121804911-G-A, CADD 23.20
- M59V (p.Met59Val), TOPMed rs1186776060, ESM-1b 0.00, AlphaMissense 0.08
- M59I (p.Met59Ile), gnomAD 12-121805120-G-A, REVEL 0.33, ESM-1b 0.00
- S60S (p.Ser60Ser), rs1159258575, gnomAD 12-121805123-C-T, CADD 14.20
- S61G (p.Ser61Gly), cosmic curated COSV99930, ESM-1b 0.00, AlphaMissense 0.13
- S61N (p.Ser61Asn), cosmic curated COSV99930, ESM-1b 0.00, AlphaMissense 0.39
- S61R (p.Ser61Arg), gnomAD 12-121805124-A-C, REVEL 0.30, ESM-1b 0.00
- N62S (p.Asn62Ser), rs2500164954, ClinGen CA386987347, ClinVar RCV002289149, REVEL 0.24, ESM-1b 0.00, Uncertain significance, Intellectual developmental disorder with seizures and language delay
- R63H (p.Arg63His), gnomAD rs1875663921, REVEL 0.23, ESM-1b 0.00
- R63R (p.Arg63Arg), gnomAD 12-121805132-C-G, CADD 12.20
- P64S (p.Pro64Ser), gnomAD 12-121805133-C-T, REVEL 0.57, ESM-1b 0.00
- P64A (p.Pro64Ala), gnomAD 12-121805133-C-G, REVEL 0.43, ESM-1b 0.00
- P64Q (p.Pro64Gln), gnomAD 12-121805134-C-A, REVEL 0.82, ESM-1b 0.00
- P64P (p.Pro64Pro), gnomAD 12-121805135-G-C, CADD 12.50
- V65A (p.Val65Ala), cosmic curated COSV57349, ESM-1b 0.00, AlphaMissense 0.97
- V65V (p.Val65Val), rs1394308288, gnomAD 12-121805138-G-A, CADD 13.70
- E66Q (p.Glu66Gln), gnomAD 12-121805139-G-C, REVEL 0.25, ESM-1b 0.00
- E66K (p.Glu66Lys), gnomAD 12-121805139-G-A, REVEL 0.39, ESM-1b 0.00
- E66E (p.Glu66Glu), gnomAD 12-121805141-A-G, CADD 9.02
- I67V (p.Ile67Val), gnomAD 12-121805142-A-G, REVEL 0.20, ESM-1b 0.00
- I67T (p.Ile67Thr), gnomAD 12-121805143-T-C, REVEL 0.30, ESM-1b 0.00
- I67I (p.Ile67Ile), gnomAD 12-121805144-T-A, CADD 12.20
- V68G (p.Val68Gly), gnomAD rs1307525979, REVEL 0.73, ESM-1b 0.00
- V68V (p.Val68Val), gnomAD 12-121805147-C-G, CADD 9.34
- E69Q (p.Glu69Gln), gnomAD rs1362571981, REVEL 0.17, ESM-1b 0.00
- E69D (p.Glu69Asp), gnomAD 12-121805150-A-C, REVEL 0.28, ESM-1b 0.00
- E69E (p.Glu69Glu), gnomAD 12-121805150-A-G, CADD 12.80
- D70V (p.Asp70Val), cosmic curated COSV57348, ESM-1b 0.67, AlphaMissense 1.00
- D70D (p.Asp70Asp), gnomAD 12-121805153-T-C, CADD 12.50
- P71P (p.Pro71Pro), rs1244069940, gnomAD 12-121805156-C-T, CADD 13.40
- R72R (p.Arg72Arg), gnomAD 12-121805157-C-A, CADD 13.70
- V73F (p.Val73Phe), gnomAD 12-121805160-G-T, REVEL 0.58, ESM-1b 0.93
- V73V (p.Val73Val), rs1235537005, gnomAD 12-121805162-C-T, CADD 9.38
- V74I (p.Val74Ile), ESP rs376274057, TOPMed rs376274057, gnomAD rs376274057, REVEL 0.21, ESM-1b 0.00
- V74V (p.Val74Val), rs898624591, gnomAD 12-121805165-C-T, CADD 12.50
- G75R (p.Gly75Arg), cosmic curated COSV11397, ESM-1b 0.00, AlphaMissense 0.96
- G75G (p.Gly75Gly), rs370308024, gnomAD 12-121805168-G-C, CADD 7.42
- I76V (p.Ile76Val), Ensembl rs1875666259, ESM-1b 0.00, AlphaMissense 0.57
- I76L (p.Ile76Leu), gnomAD 12-121805169-A-C, REVEL 0.31, ESM-1b 0.00
- I76I (p.Ile76Ile), rs778459813, gnomAD 12-121805171-C-T, CADD 13.70
- W77* (p.Trp77Ter), cosmic curated COSV10957, CADD 38.00
- W77L (p.Trp77Leu), cosmic curated COSV99930, ESM-1b 0.63, AlphaMissense 0.99
- W77R (p.Trp77Arg), gnomAD 12-121805172-T-C, REVEL 0.63, ESM-1b 0.00
Public SETD1B analysis runs
- SETD1B analysis run — SETD1B (2,368 variants) — completed 2026-10-09